Toxinology in Brazil: A big challenge for a rich biodiversity
Authors:
- Consuelo Latorre Fortes-DiasCFConsuelo Latorre Fortes-Dias
- Célia R. CarliniCélia R. Carlini
- Jorge A. GuimarãesJGJorge A. Guimarães
- 15 December 2010
- Vol. 56 (7) , 1084-1091
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Most cited papers in ToxiconToxicon, 2004
- Karl Heinrich Slotta (1895–1987) biochemist: snakes, pregnancy and coffeeToxicon, 2001
- Maurício Rocha E Silva MD: Snake venom, bradykinin and the rise of autopharmacologyToxicon, 1997
- Phospholipase A2—a structural reviewToxicon, 1996
- Pioneers of anti-venomous serotherapy: Dr Vital Brazil (1865–1950)Toxicon, 1992
- A model to explain the pharmacological effects of snake venom phospholipases A2Toxicon, 1989
- History of the international society on toxinology and Toxicon: I. The formative years, 1954–1965Toxicon, 1987
- Isolation of bradykinin-potentiating peptides from Bothrops jararaca venomBiochemistry, 1970
- Activity of Various Fractions of Bradykinin Potentiating Factor against Angiotensin I Converting EnzymeNature, 1970
- BRADYKININ, A HYPOTENSIVE AND SMOOTH MUSCLE STIMULATING FACTOR RELEASED FROM PLASMA GLOBULIN BY SNAKE VENOMS AND BY TRYPSINAmerican Journal of Physiology-Legacy Content, 1949